UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of a "Just-in-Time" Nurse Consultation on Bone Health: A Pilot Randomized Controlled Trial

Permanente journal, 2017, Vol.21 (4), p.16-112

2017

Volltextzugriff (PDF)

Haplotypes of the angiotensin II receptor genes AGTR1 and AGTR2 in women with normotensive pregnancy and women with preeclampsia

Human mutation, 2004-07, Vol.24 (1), p.14-20

2004

Volltextzugriff (PDF)

Haplotypes of the angiotensin II receptor genesAGTR1 andAGTR2 in women with normotensive pregnancy and women with preeclampsia

Human mutation, 2004-07, Vol.24 (1), p.14-20

2004

Volltextzugriff (PDF)

P4-074 Alpha-1-antichymotrypsin (ACT) gene haplotyping in Alzheimer's disease (AD)

Neurobiology of aging, 2004-07, Vol.25, p.S495-S495

2004

Volltextzugriff (PDF)

P4-043 Gene expression profiles of primary human astrocytes exposed to Abeta and ACT/ABETA complexes assessed using a global DNA microarray

Neurobiology of aging, 2004-07, Vol.25, p.S485-S485

2004

Volltextzugriff (PDF)

Studies of the angiotensinogen and the angiotensin ii receptor genes in normal and pre-eclamptic pregnancy

Plummer, Sally

2001

Volltextzugriff (PDF)

Topical ciprofloxacin for otorrhea after tympanostomy tube placement

Archives of otolaryngology--head & neck surgery, 1995-08, Vol.121 (8), p.880-884

1995

Volltextzugriff (PDF)

The intelligibility of speech by hearing aids on inductance loop and microphone modes of signal reception

Journal of speech and hearing research, 1970-03, Vol.13 (1), p.87-91

1970

Volltextzugriff (PDF)

THE EFFECTS OF TWENTY-TWO CONDITIONS OF BAND-PASS FILTERING ON THREE TYPES OF VERBAL MATERIAL

PLUMMER, SALLY ANN

1972

Volltextzugriff (PDF)

Novel Polymorphisms in the Angiotensin II type 2 Receptor Gene: Common Haplotypes and Implications for Intrauterine Growth Restriction (IUGR)

Clinical Science, 2002-07, Vol.103 (s47), p.60-61P

2002

Volltextzugriff (PDF)

Pain scoring systems in hospitalized horses with ocular disease

Journal of veterinary internal medicine, 2024-01, Vol.38 (1), p.388-397

2024

Volltextzugriff (PDF)

Poly(ADP-ribose) polymerase-1 (PARP-1) pharmacogenetics, activity and expression analysis in cancer patients and healthy volunteers

Biochemical journal, 2011-06, Vol.436 (3), p.671-679

2011

Volltextzugriff (PDF)

Effects of sodium-glucose transporter-2 inhibition on systemic hemodynamics, renal function, and intra-renal oxygenation in sepsis-associated acute kidney injury

Intensive care medicine experimental, 2024-07, Vol.12 (1), p.64-10, Article 64

2024

Volltextzugriff (PDF)

Genetic Overlap in Kallmann Syndrome, Combined Pituitary Hormone Deficiency, and Septo-Optic Dysplasia

The journal of clinical endocrinology and metabolism, 2012-04, Vol.97 (4), p.E694-E699

2012

Volltextzugriff (PDF)

Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial

Oncoimmunology, 2018-06, Vol.7 (6), p.e1433516-e1433516

2018

Volltextzugriff (PDF)

Phase I Study of MG98, an Oligonucleotide Antisense Inhibitor of Human DNA Methyltransferase 1, Given as a 7-Day Infusion in Patients with Advanced Solid Tumors

Clinical cancer research, 2009-05, Vol.15 (9), p.3177-3183

2009

Volltextzugriff (PDF)

Immune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infection

Nature communications, 2023-06, Vol.14 (1), p.3286-31, Article 3286

2023

Volltextzugriff (PDF)

Delivering healthcare services to children with cerebral palsy and their families: a narrative review

Health & social care in the community, 2015-05, Vol.23 (3), p.242-251

2015

Volltextzugriff (PDF)

A CRUK first-in-human phase I trial of LY3143921, a novel CDC7 inhibitor, in patients with advanced solid tumors

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3103-3103

2022

Volltextzugriff (PDF)

Abstract 3014: Pharmacokinetics of the CDC7 inhibitor LY3143921 hydrate, a CRUK first-in-human phase I trial in patients with advanced solid tumors

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.3014-3014

2020

Volltextzugriff (PDF)

Olaparib does not cause clinically relevant QT/QTc interval prolongation in patients with advanced solid tumours: results from two phase I studies

Cancer chemotherapy and pharmacology, 2016-10, Vol.78 (4), p.775-784

2016

Volltextzugriff (PDF)

A CRUK first-in-human phase I trial of a CDC7 Inhibitor, LY3143921 hydrate, in patients with advanced solid tumors

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.TPS3167-TPS3167

2019

Volltextzugriff (PDF)

Olaparib does not cause clinically relevant QT/QT sub(c) interval prolongation in patients with advanced solid tumours: results from two phase I studies

Cancer chemotherapy and pharmacology, 2016-10, Vol.78 (4), p.775-784

2016

Volltextzugriff (PDF)

Olaparib does not cause clinically relevant QT/QT^sub c^ interval prolongation in patients with advanced solid tumours: results from two phase I studies

Cancer chemotherapy and pharmacology, 2016-10, Vol.78 (4), p.775

2016

Volltextzugriff (PDF)

Blocking and suppressing mechanisms of chemoprevention by dietary constituents

Toxicology letters, 2000-03, Vol.112 (1-3), p.499-505

2000

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(23)

Publikationsform

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Evaluation of a "Just-in-Time" Nurse Consultation on Bone Health: A Pilot Randomized Controlled Trial

Haplotypes of the angiotensin II receptor genes AGTR1 and AGTR2 in women with normotensive pregnancy and women with preeclampsia

Haplotypes of the angiotensin II receptor genesAGTR1 andAGTR2 in women with normotensive pregnancy and women with preeclampsia

P4-074 Alpha-1-antichymotrypsin (ACT) gene haplotyping in Alzheimer's disease (AD)

P4-043 Gene expression profiles of primary human astrocytes exposed to Abeta and ACT/ABETA complexes assessed using a global DNA microarray

Studies of the angiotensinogen and the angiotensin ii receptor genes in normal and pre-eclamptic pregnancy

Topical ciprofloxacin for otorrhea after tympanostomy tube placement

The intelligibility of speech by hearing aids on inductance loop and microphone modes of signal reception

THE EFFECTS OF TWENTY-TWO CONDITIONS OF BAND-PASS FILTERING ON THREE TYPES OF VERBAL MATERIAL

Novel Polymorphisms in the Angiotensin II type 2 Receptor Gene: Common Haplotypes and Implications for Intrauterine Growth Restriction (IUGR)

Pain scoring systems in hospitalized horses with ocular disease

Poly(ADP-ribose) polymerase-1 (PARP-1) pharmacogenetics, activity and expression analysis in cancer patients and healthy volunteers

Effects of sodium-glucose transporter-2 inhibition on systemic hemodynamics, renal function, and intra-renal oxygenation in sepsis-associated acute kidney injury

Genetic Overlap in Kallmann Syndrome, Combined Pituitary Hormone Deficiency, and Septo-Optic Dysplasia

Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial

Phase I Study of MG98, an Oligonucleotide Antisense Inhibitor of Human DNA Methyltransferase 1, Given as a 7-Day Infusion in Patients with Advanced Solid Tumors

Immune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infection

Delivering healthcare services to children with cerebral palsy and their families: a narrative review

A CRUK first-in-human phase I trial of LY3143921, a novel CDC7 inhibitor, in patients with advanced solid tumors

Abstract 3014: Pharmacokinetics of the CDC7 inhibitor LY3143921 hydrate, a CRUK first-in-human phase I trial in patients with advanced solid tumors

Olaparib does not cause clinically relevant QT/QTc interval prolongation in patients with advanced solid tumours: results from two phase I studies

A CRUK first-in-human phase I trial of a CDC7 Inhibitor, LY3143921 hydrate, in patients with advanced solid tumors

Olaparib does not cause clinically relevant QT/QT sub(c) interval prolongation in patients with advanced solid tumours: results from two phase I studies

Olaparib does not cause clinically relevant QT/QT^sub c^ interval prolongation in patients with advanced solid tumours: results from two phase I studies

Blocking and suppressing mechanisms of chemoprevention by dietary constituents

Suchergebnisse filtern